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T
 he inaugural issue of Kidney International, 
then a monthly, contained seven articles, 
whose titles included the words ‘kidney’ 
and ‘renal’ twice each, but not ‘kidney dis-
ease’ or ‘end-stage renal disease.’ By contrast, the 
last issue in 2006 of Kidney International, now a 
semimonthly, contained 17 articles, whose titles 
included the terms ‘kidney,’ ‘renal,’ and ‘end-stage 
renal disease’ three times each, and ‘kidney dis-
ease’ twice. Th e change in number of articles and 
in vocabulary refl ects the evolution of the Inter-
national Society of Nephrology and the discipline 
that its offi  cial journal represents.
Kidney disease: Wherefore?
Several events contributed to the emergence of 
nephrology during the decades following the Sec-
ond World War. First was the increasing number 
of publications centered on kidney function. Th ese 
were stimulated in part by studies initiated during 
the war on the eff ects of shock and adaptation to 
climatic changes on hemodynamics, and the post-
war proliferation of new drugs that had a diuretic 
eff ect or whose clearance depended on the kidney. 
Second was the introduction of new technologies 
of clinical relevance to kidney disease, specifi cally 
dialysis, transplantation, and kidney biopsy. Th is 
led to the fi rst International Congress of Neph-
rology in 1960, which brought into being the 
International Society of Nephrology immediately 
thereaft er.1 What led to the subsequent exponential 
growth of the budding discipline was hemodialy-
sis. Begun as exploratory attempts to sustain the 
lives of selected patients in the 1950s, hemodialysis 
changed kidney failure from a fatal to a treatable 
disease aft er the introduction of permanent vascu-
lar access in the 1960s and evolved into life-saving 
replacement therapy for millions worldwide, and 
with it the term ‘end-stage renal disease’ became 
ingrained in the parlance of nephrology.
As data on maintenance hemodialysis accrued, 
it became evident in the 1980s that there were 
signifi cant variations in the outcomes of dialy-
sis patients. Concern over these issues led to the 
development of clinical practice guidelines in 
nephrology, notably those under the banner of 
the Dialysis Outcomes Quality Initiative (DOQI), 
published in 1997.2 During the development of the 
DOQI guidelines, it became evident that the care 
of these patients should be initiated well before the 
need for dialysis, and that in fact an even greater 
opportunity existed to improve outcomes for indi-
viduals at earlier stages of kidney disease.3 Th is had 
become possible because of interim advances in 
understanding the progressive course of kidney 
disease and its complications, and the introduction 
of interventions that could slow the progression 
and ameliorate the complications of the disease.4 It 
was on this basis that in the fall of 1999 a decision 
was made to move into a new phase of nephrol-
ogy guidelines in which the scope of work would 
be enlarged to encompass the entire spectrum of 
kidney disease. To refl ect this change, the reference 
to ‘dialysis’ in DOQI was changed to ‘disease,’ and 
the new initiative was termed the Kidney Disease 
Outcomes Quality Initiative (KDOQI).2
Th e decision to use ‘kidney disease’ was delib-
erate. If the new initiative was going to have its 
envisioned impact, it was essential to convey its 
message to patients, providers, and legislators in 
words that they could understand, not a language 
that is learned in medical school.
Kidney disease: Whence?
Where did ‘kidney disease come from’? To quote 
Shakespeare (1564–1616), “that which we call 
a rose by any other name would smell as sweet” 
(Romeo and Juliet), and, as paraphrased by Ger-
trude Stein (1874–1946) in her unique style, “Rose 
is a rose is a rose is a rose” (Sacred Emily). Essen-
tially, when all is said and done, a thing is what it is. 
But until a thing has a name it is not part of human 
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Figure 1 | The words for ‘kidney’ in different 
languages.
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consciousness, because in any language it is words, 
be they spoken or written, that off er a bridge from 
one mind to another — a concept that was much 
debated by the philosophers of ancient Greece, 
in whose language the term for ‘word,’ logos, also 
meant speech, discourse, and reason.5
Any word in any language is an arbitrary associ-
ation of certain sounds with a given meaning.6 Th e 
more widely the iconography of a word is under-
stood by individuals using a common language, 
the more valuable the word will be in commu-
nication; and the more precise is the association 
of that word with a meaning, the more accurate 
the communication will be. As such, the use of 
‘kidney’ in ‘kidney disease’ solves the communica-
tion problem in English but not in other languages 
(Figure 1). Actually, it presents a new problem 
because of its foreign sound as compared with 
its counterparts in the other Romance languages 
(rein, rene, rin) and Germanic languages (nere, 
nier, nyre), to whose families English belongs. Th e 
English word stands out in contrast to the others 
by its fi rst element (kid). Th e origin of the second 
element (ney) is inferred to be from a Germanic 
root (nere), but that of the fi rst remains uncertain.5 
Th ese phonetic challenges notwithstanding, Eng-
lish has become the lingua franca of the world, a 
process now accelerated by the Internet. More than 
two-thirds of world scientists report their fi ndings 
in English,6 which is the language in which Kid-
ney International is published — hence the broader 
implications of incorporating ‘kidney disease’ in 
the language of nephrology.
Despite its linguistic challenges, what led to the 
acceptance, impact, and adoption of ‘kidney dis-
ease’ was the decision that the fi rst clinical practice 
guidelines developed by KDOQI  would be on the 
defi nition, evaluation, classifi cation, and stratifi ca-
tion of chronic kidney disease (CKD). Th e terms 
used theretofore (‘chronic renal failure,’ ‘chronic 
renal disease,’ ‘chronic renal insuffi  ciency,’ ‘predi-
alysis,’ ‘pre-end-stage renal disease’), and unfor-
tunately still used by some, were poorly defi ned, 
ambiguous, based on medical terms that are foreign 
to the public, and centered on end-stage renal dis-
ease and dialysis.7 By providing a precise defi nition 
of CKD and its classifi cation based on the severity 
of the disease as determined by the glomerular fi l-
tration rate (GFR), these guidelines provided for 
the fi rst time a precise defi nition that was applicable 
in clinical practice and research.8 Th eir acceptance 
by the world medical community and their impact 
on the elucidation of the epidemiology of CKD are 
a matter of record. Th ey have helped bring kidney 
disease to the attention of health authorities world-
wide, as is perhaps best illustrated by the mention 
of kidney disease, alongside other major chronic 
diseases, by the new director general of the World 
Health Organization.9
Kidney disease: Whereto?
By any criteria, the paradigm shift  introduced by 
these guidelines is a milestone in the evolution 
of nephrology, but it is not without limitations. 
Although considerable eff ort went into develop-
ing an evidence base for the proposed classifi cation 
of CKD, the evidence available then was actually 
limited. Thus, the proposed classification may 
require refi nement as new evidence accrues. In the 
meantime, at two international meetings convened 
by Kidney Disease: Improving Global Outcomes 
(KDIGO), the consensus was to adhere to the cur-
rent simple classifi cation.10 Another limitation of 
the classifi cation is the formulae used to estimate 
the GFR, which in fact is a better clinical indica-
tor of kidney function than creatinine, previously 
used as the main indicator. What is encouraging is 
the worldwide eff ort now under way to standardize 
the measurement of creatinine and determine the 
applicability of a formula to estimate GFR.11 Th is is 
certainly a fi rst step toward the basic concept prom-
ulgated by one of the principal founding fathers of 
nephrology, Homer Smith (1895–1962), that the 
best measure of kidney function is the GFR. Rel-
evant in this regard is another legacy Smith tried to 
impart in his use of the word ‘kidney’ in the titles of 
his classic texts Th e Physiology of the Kidney (1937) 
and Th e Kidney: Structure and Function in Health 
and Disease (1951).
In defining CKD as kidney damage present 
for at least 3 months, the KDOQI guidelines also 
identifi ed the issue of potentially reversible kidney 
injury of less than 3 months’ duration as a separate 
issue that needed to be addressed. Th e evolution 
of the eff ort to resolve this problem has mirrored 
that of the eff ort against CKD in its initial focus 
on dialysis, when the challenge was fi rst taken up 
by an impromptu group of investigators as the 
Acute Dialysis Quality Initiative.12 Its eff orts are 
refl ected in the introduction of the term ‘acute 
kidney injury’ (AKI), which has become a topic of 
increasing interest, resulting in the formation of 
an inter-organizational group known as the Acute 
Kidney Injury Network (AKIN) to facilitate edu-
cational, research, and other AKI-related initiatives 
in a collaborative manner.13 A general consensus 
that has come out of AKIN meetings is the need for 
evidence-based guidelines for the care of patients 
with AKI. In December 2006, the KDIGO board of 
directors approved the development of evidence-
based clinical practice guidelines for AKI, along the 
lines of those developed for CKD. It will be some 
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time before these guidelines reach fruition, but the 
process has been initiated and should help bring 
this facet of kidney disease into clearer focus.
Conclusion
The International Society of Nephrology was 
launched predominantly by speakers of the 
Romance languages, hence the name of its fi rst 
offi  cial publication, Nephron, and its content of 
articles in French and English. Th e circumstances 
that led to the subsequent abandonment of Neph-
ron and the launching of Kidney International in 
1972 have been recorded.1 One can only speculate 
as to whether this change was attributable to cir-
cumstance, the foresight of the founders of Kidney 
International, or providence. Th e fact remains that 
the journal now carries the name of the diseased 
organ that had to wait 30 years for its incorporation 
into the language of nephrology.
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